These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33759682)

  • 1. Low pH Hypromellose (Taffix) nasal powder spray could reduce SARS-CoV-2 infection rate post mass-gathering event at a highly endemic community: an observational prospective open label user survey.
    Shmuel K; Dalia M; Tair L; Yaakov N
    Expert Rev Anti Infect Ther; 2021 Oct; 19(10):1325-1330. PubMed ID: 33759682
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxypropyl Methylcellulose-Based Nasal Sprays Effectively Inhibit In Vitro SARS-CoV-2 Infection and Spread.
    Bentley K; Stanton RJ
    Viruses; 2021 Nov; 13(12):. PubMed ID: 34960612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers : A Randomized Controlled Trial.
    Bundgaard H; Bundgaard JS; Raaschou-Pedersen DET; von Buchwald C; Todsen T; Norsk JB; Pries-Heje MM; Vissing CR; Nielsen PB; Winsløw UC; Fogh K; Hasselbalch R; Kristensen JH; Ringgaard A; Porsborg Andersen M; Goecke NB; Trebbien R; Skovgaard K; Benfield T; Ullum H; Torp-Pedersen C; Iversen K
    Ann Intern Med; 2021 Mar; 174(3):335-343. PubMed ID: 33205991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Concept for the Reduction of Mucosal SARS-CoV-2 Load using Hypochloric Acid Solutions.
    Mueller CA; Winter M; Renner B
    Drug Res (Stuttg); 2021 Jul; 71(6):348-350. PubMed ID: 33890267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of nitric oxide nasal spray (NONS) for the treatment of mild COVID-19 infection.
    Winchester S; John S; Jabbar K; John I
    J Infect; 2021 Aug; 83(2):237-279. PubMed ID: 33992687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-Free Nasal Spray as a Barrier against SARS-CoV-2 and Its Delta Variant: In Vitro Study of Safety and Efficacy in Human Nasal Airway Epithelia.
    Fais F; Juskeviciene R; Francardo V; Mateos S; Guyard M; Viollet C; Constant S; Borelli M; Hohenfeld IP
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
    Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
    Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Hydroxychloroquine Use Is Not Significantly Associated with Positive PCR Results for SARS-CoV-2: A Nationwide Observational Study in South Korea.
    Bae S; Ghang B; Kim YJ; Lim JS; Yun SC; Kim YG; Lee SO; Kim SH
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33672785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, characterisation and nasal deposition of melatonin-loaded pectin/hypromellose microspheres.
    Nižić L; Potaś J; Winnicka K; Szekalska M; Erak I; Gretić M; Jug M; Hafner A
    Eur J Pharm Sci; 2020 Jan; 141():105115. PubMed ID: 31654755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community Outbreak Investigation of SARS-CoV-2 Transmission Among Bus Riders in Eastern China.
    Shen Y; Li C; Dong H; Wang Z; Martinez L; Sun Z; Handel A; Chen Z; Chen E; Ebell MH; Wang F; Yi B; Wang H; Wang X; Wang A; Chen B; Qi Y; Liang L; Li Y; Ling F; Chen J; Xu G
    JAMA Intern Med; 2020 Dec; 180(12):1665-1671. PubMed ID: 32870239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary study on contact tracing & transmission chain in a cluster of 17 cases of severe acute respiratory syndrome coronavirus 2 infection in Basti, Uttar Pradesh, India.
    Kant R; Zaman K; Shankar P; Yadav R;
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):95-99. PubMed ID: 32811800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-collection: An appropriate alternative during the SARS-CoV-2 pandemic.
    Wehrhahn MC; Robson J; Brown S; Bursle E; Byrne S; New D; Chong S; Newcombe JP; Siversten T; Hadlow N
    J Clin Virol; 2020 Jul; 128():104417. PubMed ID: 32403007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
    Dixon BE; Wools-Kaloustian KK; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
    PLoS One; 2021; 16(3):e0241875. PubMed ID: 33760821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Effectiveness of 1 Dose of BNT162b2 Vaccine for SARS-CoV-2 Infection 13 to 24 Days After Immunization.
    Chodick G; Tene L; Patalon T; Gazit S; Ben Tov A; Cohen D; Muhsen K
    JAMA Netw Open; 2021 Jun; 4(6):e2115985. PubMed ID: 34097044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Serological testing in frontline health workers in Zimbabwe.
    Rusakaniko S; Sibanda EN; Mduluza T; Tagwireyi P; Dhlamini Z; Ndhlovu CE; Chandiwana P; Chiwambutsa S; Lim RM; Scott F; Sibanda LM; Mutapi F
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009254. PubMed ID: 33788840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Numerical evaluation of spray position for improved nasal drug delivery.
    Basu S; Holbrook LT; Kudlaty K; Fasanmade O; Wu J; Burke A; Langworthy BW; Farzal Z; Mamdani M; Bennett WD; Fine JP; Senior BA; Zanation AM; Ebert CS; Kimple AJ; Thorp BD; Frank-Ito DO; Garcia GJM; Kimbell JS
    Sci Rep; 2020 Jun; 10(1):10568. PubMed ID: 32601278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic and features of SARS-CoV-2 infection in Gabon.
    Mveang Nzoghe A; Padzys GS; Maloupazoa Siawaya AC; Kandet Yattara M; Leboueny M; Avome Houechenou RM; Bongho EC; Mba-Mezeme C; Mvoundza Ndjindji O; Biteghe-Bi-Essone JC; Boulende A; Essone PN; Ndong Sima CAA; Minkobame U; Zang Eyi C; Ndeboko B; Voloc A; Meye JF; Ategbo S; Djoba Siawaya JF
    Sci Rep; 2021 May; 11(1):9672. PubMed ID: 33958601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India.
    Khan MS; Haq I; Qurieshi MA; Majid S; Bhat AA; Qazi TB; Chowdri IN; Sabah I; Kawoosa MF; Lone AA; Nabi S; Sumji IA; Obaid M; Kousar R
    J Hosp Med; 2021 May; 16(5):274-281. PubMed ID: 33929947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis.
    Landi D; Ponzano M; Nicoletti CG; Cecchi G; Cola G; Mataluni G; Mercuri NB; Sormani MP; Marfia GA
    Mult Scler Relat Disord; 2020 Oct; 45():102359. PubMed ID: 32663793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community Use of Face Masks against the Spread of COVID-19.
    Bubbico L; Mastrangelo G; Larese-Filon F; Basso P; Rigoli R; Maurelli M; Ferlito S; Capelli M; Gisabella C; Javanbakht M; Bellizzi S; Cegolon L
    Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33808861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.